Equity Capital Markets

All filings · since 4 November 2002

Filings

Every share-offering filing on EDGAR since the day foreign issuers also had to file electronically. One row per filer: a filing made by a parent and its subsidiaries appears once for each of them, as in SEC's own index.

Page 1 · newest first · 50 per pageDownload as CSV (up to 5,000 rows)
FiledCompanyFilingAccession
2026-04-01
LeonaBio, Inc.
ShelfEffectiveCIK 1620463
 EFFECTDeclared effective9999999995-26-001046
2026-04-01
LeonaBio, Inc.
ShelfEffectiveCIK 1620463
 EFFECTDeclared effective9999999995-26-001045
2026-03-31
LeonaBio, Inc.
ShelfEffectiveCIK 1620463
 S-1/AAmendment0001193125-26-134904
2026-03-31
LeonaBio, Inc.
ShelfEffectiveCIK 1620463
 S-1/AAmendment0001193125-26-134866
2026-01-20
LeonaBio, Inc.
ShelfEffectiveCIK 1620463
 S-3Shelf registered0001193125-26-016699
2026-01-20
LeonaBio, Inc.
ShelfEffectiveCIK 1620463
 S-3Shelf registered0001193125-26-016629
2024-10-28
Athira Pharma, Inc.
ShelfEffectiveCIK 1620463
 EFFECTDeclared effective9999999995-24-003298
2024-10-21
Athira Pharma, Inc.
ShelfEffectiveCIK 1620463
 S-3Shelf registered0000950170-24-115736
2023-01-06
Athira Pharma, Inc.
ShelfEffectiveCIK 1620463
 424B5Shelf takedown0000950170-23-000361
2021-11-24
Athira Pharma, Inc.
ShelfEffectiveCIK 1620463
 EFFECTDeclared effective9999999995-21-004485
2021-11-15
Athira Pharma, Inc.
ShelfEffectiveCIK 1620463
 S-3Shelf registered0001564590-21-057000
2021-01-21
Athira Pharma, Inc.
Registered companyFinal prospectusCIK 1620463
 424B4Final prospectus0001564590-21-001770
2021-01-20
Athira Pharma, Inc.
Registered companyFinal prospectusCIK 1620463
 EFFECTDeclared effective9999999995-21-000203
2021-01-19
Athira Pharma, Inc.
Registered companyFinal prospectusCIK 1620463
 S-1Registration filed0001564590-21-001397
2021-01-06
Athira Pharma, Inc.
CIK 1620463
 DRSDraft made public0000950123-21-000032
2020-09-18
Athira Pharma, Inc.
IPOFinal prospectusCIK 1620463
 424B4Final prospectus0001564590-20-043998
2020-09-17
Athira Pharma, Inc.
IPOFinal prospectusCIK 1620463
 EFFECTDeclared effective9999999995-20-002483
2020-09-17
Athira Pharma, Inc.
IPOFinal prospectusCIK 1620463
 S-1/AAmendment0001564590-20-043758
2020-09-14
Athira Pharma, Inc.
IPOFinal prospectusCIK 1620463
 S-1/AAmendment0001564590-20-043324
2020-09-09
Athira Pharma, Inc.
IPOFinal prospectusCIK 1620463
 S-1/AAmendment0001564590-20-042848
2020-08-26
Athira Pharma, Inc.
IPOFinal prospectusCIK 1620463
 S-1Registration filed0001564590-20-041369
2020-07-24
Athira Pharma, Inc.
CIK 1620463
 DRSDraft made public0000950123-20-007179